Ginkgo Bioworks Holdings (DNA) short interest & short volume · 17.3% of float short
Ginkgo Bioworks Holdings official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.
What changed
DNA short interest rose 13.4% to 8.3M shares in the Oct 15, 2026 report (17.3% of float, 1.9 days to cover). Daily short volume averaged 52.0% of volume over the last 20 sessions, down from 58.9% the 20 sessions before, the 13th percentile of its own 20-day averages since Sep 23, 2025.
Short interest
Official, twice monthly · settled Oct 15, 2026
- Shares short
- 8.3M
- prior 7.3M
- % of float
- 17.3%
- float 47.9M
- Days to cover
- 1.9
- avg vol 4.4M
- Change vs prior report
- +13.4%
Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.
% of float uses the current float for every report (no float was stored with older reports).
Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026
Daily short volume
Share of each day's volume sold short · FINRA Reg SHO
- Latest (Nov 2)
- 58.6%
- 669K of 1.1M
- 20-day average
- 52.0%
- prior 58.9%
- Percentile vs own history
- 13th
- 233 periods since 2025
Loading prices…
Source: FINRA Reg SHO daily short sale volume · Latest Nov 2, 2026
Short squeeze score (model)
Price since settlement: -8.5%
Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.
DNA's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr
Market-wide: most shorted stocks, biggest changes and unusual short volume · DNA overview
| Date | Short | Total | Short % of volume |
|---|---|---|---|
| 2026-11-02 | 669,016 | 1,142,152 | 58.6% |
| 2026-10-30 | 586,737 | 1,118,102 | 52.5% |
| 2026-10-29 | 681,299 | 1,164,725 | 58.5% |
| 2026-10-28 | 1,060,406 | 1,875,703 | 56.5% |
| 2026-10-27 | 570,235 | 1,196,554 | 47.7% |
| 2026-10-26 | 186,705 | 392,647 | 47.5% |
| 2026-10-23 | 206,587 | 469,753 | 44.0% |
| 2026-10-22 | 365,334 | 782,697 | 46.7% |
| 2026-10-21 | 420,485 | 750,431 | 56.0% |
| 2026-10-20 | 489,103 | 990,610 | 49.4% |
Healthcare peers with similar quant ratings
DNA is rated 1.58 of 5 among 532 rated Healthcare stocks (Lician quant rating, Nov 4, 2026). How the rating works
- CRSP short interest1.61 · Sell · stock
- STRO short interest1.61 · Sell · stock
- ANGO short interest1.60 · Sell · stock
- ACHV short interest1.59 · Sell · stock
- SRRK short interest1.58 · Sell · stock
- JBIO short interest1.57 · Sell · stock
- RAPP short interest1.56 · Sell · stock
- CRVS short interest1.55 · Sell · stock
DNA short interest FAQ
What is DNA's short interest?
Ginkgo Bioworks Holdings (DNA) had 8.3M shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report, 17.3% of its 47.9M-share float.
How many days to cover does DNA have?
1.9 days: 8.3M shares short divided by an average daily volume of 4.4M for the Oct 15, 2026 period.
Is DNA short interest rising or falling?
DNA short interest rose (+13.4%) from 7.3M to 8.3M shares in the Oct 15, 2026 report.
Is DNA a short squeeze candidate?
Lician's squeeze watch scores DNA 32 out of 100 (low) from the Oct 15, 2026 report: short interest % of float 23.1/40, days to cover 4.7/25, change in short interest vs prior report 4/15, price change since settlement date 0/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.
What share of DNA daily volume is sold short?
52.0% on average over the last 20 sessions to Nov 2, 2026 (FINRA Reg SHO daily short volume; the 13th percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.
What was DNA's latest FINRA short volume?
On Nov 2, 2026, cached FINRA short volume for Ginkgo Bioworks Holdings (DNA) was 669,016 shares, 58.6% of 1,142,152 total volume.
How many DNA short-volume sessions are listed on this page?
This page lists 10 cached FINRA short-volume sessions for Ginkgo Bioworks Holdings (DNA), from Oct 20, 2026 through Nov 2, 2026.
How did DNA short volume percent change from the prior cached session?
Cached FINRA short volume for Ginkgo Bioworks Holdings (DNA) moved from 52.5% on Oct 30, 2026 to 58.6% on Nov 2, 2026, up 6.1 percentage points.
Not investment advice. Figures as filed or reported, not a live feed.